Aligos Therapeutics, Inc (ALGS) insider trading

Every open-market stock purchase and sale by Aligos Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • Last insider buy: Carole Nuechterlein (Insider), $6M, 2 years ago.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent ALGS insider trades

DateInsiderTradeValue
Jun 25, 2026Heather Preston (Insider)Bought (not open market)—
Jun 25, 2026Peter Hirth (Insider)Bought (not open market)—
Jun 25, 2026Bridget A Martell (Insider)Bought (not open market)—
Jun 25, 2026Margarita Chavez (Insider)Bought (not open market)—
Jun 25, 2026James Paul Scopa (Insider)Bought (not open market)—
Jun 25, 2026Carole Nuechterlein (Insider)Bought (not open market)—
Mar 9, 2026Lawrence Blatt (CEO)Bought (not open market)—
Mar 9, 2026Julian A. Symons (Insider)Bought (not open market)—
Mar 9, 2026Lesley Ann Calhoun (Insider)Bought (not open market)—
Mar 9, 2026Nikhil Aneja (Insider)Bought (not open market)—

Who's trading ALGS

Get free alerts when an insider at Aligos Therapeutics, Inc files a new trade →